Mamentas, Jenalyn .

HRN: 05-57-15  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/08/2026
04/08/2026
IV
2g
PTOR
STAT PELVIC LAP
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines